about
Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients.The role of the pharmacist in optimizing the use of erythropoietin stimulating agents.Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation.Cognitive dysfunction and cancer: which consequences in terms of disease management?Management of anemia in cancer patients.
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Erythropoietin in cancer-related anemia.
@en
Erythropoietin in cancer-related anemia.
@nl
type
label
Erythropoietin in cancer-related anemia.
@en
Erythropoietin in cancer-related anemia.
@nl
prefLabel
Erythropoietin in cancer-related anemia.
@en
Erythropoietin in cancer-related anemia.
@nl
P1476
Erythropoietin in cancer-related anemia.
@en
P2093
Arnold Ganser
P304
P356
10.1097/CCO.0B013E3283136971
P577
2008-11-01T00:00:00Z